|Articles|June 10, 2016
Trends in Controlled Release Drugs
Advertisement
Pharmaceutical Technology sat down with Mike Valazza, vice-president of business development, Catalent Pharma Solutions to discuss modified-release formulations.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
PharmTech Weekly Roundup—June 19, 2026
4
Why the First Generic Single-Dose Flu Antiviral Approval Matters
5